We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Notnow20 ,
If you think that it's stupid to analyse the various options , then so be it
I for one think that it's important to evaluate and debate the options , not for the reason of being ´right ´ or I told you so ´ but to be ready to react to this scenario or the other ... When one is prepared , one will be able to react accordingly ....
In my experience biotech investing is all about watching the angles ( and your back ) because as said before , the unexpected happens regularly .
Nolupus
I was just asking you, as you said we should be focusing on that.
L2 seems different today. It’s nice to see some blue. There has been some chunky delayed trades, but maybe just maybe we are through the worst. Bring on the Lansdowne TR1 !!!
I'm here for the result??? Result(s)…..we got three shots on goal here - we only need to score one and we will be well north of the most unluckiest pi who brought at the peak of a spike!
Sharestring ,
Who is buying ?
Well , without any TR-1 it's difficult to say , don't you think ?
Many PI, including myself have bought more , but that does'nt explain the daily volumes ...
When one sees 300k + trades going through , it's hard to imagine that it's PI Who are buying .....
Notnow20 ,
I know it's ´popular ´ on this board to pest about me and my contrarien posts .
You amongst others have wanted me filtered or musseled since the beginning .
If you have learnt nothing from my posts then tough luck on you :-)
This is not a popularity contest but a place of debate where both sides of the coin should be exposed....
There are those like you who only want to see your own viewpoint reinforced and have the others shut up :-)
So who do you think is buying Nolupus ?
Nolupus - Yep good point who is buying I think from what others have posted here it's easier to defer TR1 disclosure on the way up than on the way down so we could end up with a nice surprise at some point.
But the share price is doing the talking in that the aggressor is definitely the seller at this point in time.
Simmo - Agreed the presence of Licht is reassuring.
GHia,
I think we should stop focusing on Lansdowne as we are only seeing the tip of the iceberg ...
Without TR-1 we are only guessing and imo lot's of shares are now ´ under the radar ´ ....
We should be asking ourselves who are buying and not just who is selling , imo
Int
Nolupus - Hopefully we will get a TR1 this week and we can stop this debate, i'd like to see the back of Lansdowne personally regardless of what they may or may not have done for SNG in the past.
Notnow - I have no idea. I wish I did. I just don’t think they are dumping stock on company policy alone. Even sharesting said he thought they reduce to 10% to derisk then stop. It s looking like That “forecast” was wrong.
Ghia,
Without talking about ´ priviligied information ´ or insider trading which we know only happens in films :-)
The II has always got a better access to information circulating in the market, than any PI....
They have access to all financial records and data from many sources
They will always be one step ahead of any PI but
They don't have access to any un published clinical data so we are all on the same footing in that context
Whilst we are solely focusing on Synairgen they will be focusing on the general market as they will have their fingers in many pies .
Some are assuming that they continue to sell here , and that they are distressed sellers , some would also point out that they have supported SNG for many years and even more recently in the last placing . We are all disappointed that the SP is not going the way we had anticipated but it's just too easy to say it's the fault of ´ distressed II ´. Imo
Chrishar- sharesting balanced?? Oh dear.
As someone who is heavily invested here and been around the lse forum for some time... ShareSting & Ghia are a breath of fresh air (as are a few others on here). Knowledgeable, well-researched, pragmatic, balanced. Thank you!
Ghia - Re Lansdown. what you say on an open forum is one thing. What happens in the real world is another. I don’t think you honestly believe that really.
Nolupus - Why would a fund manager have the ability to do better research than a PI? They are not privy to more information than a PI, that would be insider trading. They know the markets well so understand share price movements, they get called upon for funding rounds so get lucrative entry points.
But to suggest they understand the drug the company and the market better than some Pi’s is a falsehood.
They are managing a portfolio of shares so do not have time to dedicate to a small subset.
In the current volatile market it is easy for PI to outperform a fund manager as we can be more nimble with our portfolios.
A fund cannot simply just pull its holding, case an point Lansdowne here they’ve been at it for a month now.
Nolupus. Are you saying Lansdowne have insider information and are tracking every piece of research and following every interview published on Interferon. Wow they must have a large team focusing solely on Synairgen. Didn’t realise that !
IF one believes that they know more than Lansdowne who have invested millions in SNG over the years and therefore have done a hell of a lot of research into the company and it´s markets well they should maybe think again , imo
Seb46 nice try. Maybe you should follow Lansdowne investment strategy and sell up. You bring this up daily and it’s getting a little tiresome to be honest.
Lansdowne know nothing more than you me and my postman. They are one of the worst performing funds in the market. They are desperate for cash. End of
Seb- There's been no indication the other major's are pulling out or decreasing here. But for all we know they could be flipping the book and buying back there own shares through another management. Its a win win for them dependant on the end game.
Been mentioned before but a strong possibility
All imvho
this is a straight up 50:50 bet im not sure the big boys are allowed to do that with their customers money. they know as much as we do in a blind trial
DoubleD Lansdowne, what do they know? They know how to lose money this year that’s for sure. 42% down is it? I’ll not be looking to them for guidance.
Apologies if already posted.
https://uk.reuters.com/article/uk-astrazeneca-ema-lynparza-idUKKBN2382MT
disgruntled because of a higher buy in imo, there really isnt anything to worry about here though. results will be all known in the next few months..Hold for gold!
We know Lansdown have reduced their holding based on previous updates but we do not know for definite where they sit at the moment, as there has been no further declaration on their position. It is a perplexing picture, but in the meantime, the science continues to be slowly rallying round interferon it would seem, as a potential treatment to stave off the worse symptoms of Covid if administered early enough. COPD use for sng also remains a significant part of the Synairgen equation.
None of this is a guarantee this product will get to market. But a lot of effort is currently being put into getting these trials to a place where some prompt conclusions can be made.
It is going to be an ‘interesting’ and likely nervy few weeks ahead.